FOSTER CITY, Calif. -- The world's largest randomized trial of COVID-19 treatments found "conclusive evidence" that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has ...

Add Yahoo as a preferred source to see more of our stories on Google. The results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have finally been ...

Hospitalized patients who took the experimental antiviral drug remdesivir recovered from COVID-19 faster than those who took a placebo, according to a report published this week in the New England ...

A final report from a National Institutes of Health (NIH) study on the use of Remdesivir in coronavirus patients has confirmed the drug's success in speeding recovery. Gilead’s experimental antiviral ...

The new study, which used data from the Veterans Health Administration on 5,898 patients who were admitted across 123 hospitals, suggests that remdesivir may actually prolong hospital stay for some ...

A multicountry study funded by the World Health Organization found that the antiviral drug remdesivir, developed by Gilead Sciences Inc., didn't reduce deaths from Covid-19 in hospitalized patients, a ...

Recent studies have shown that patients with weakened immune systems—which enables the virus that causes COVID-19 to remain longer in the body, copy itself, and continually change—may enable the ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Much-anticipated results from the National Institute of Allergy and Infectious Diseases' clinical ...